Enantioselective Cycloisomerization of 1,5-Enynes
(6.4ϫ10–3 mmol, 4 mol-%) in toluene (0.5 mL) under argon. The
mixture was stirred at 60 °C for 18 h. The solvent was removed
under reduced pressure, the crude mixture was monitored by NMR
spectroscopy, and the final product, 4, was purified by column
chromatography with heptane/EtOAc (90:10) as the eluent. 1H
NMR (300 MHz, CDCl3): δ = 0.64 (d, 2J = 6.0 Hz, 1 H, CH2),
The enantiomerically enriched substrates 3d were sub-
jected to cycloisomerization in the presence of either PtCl2
or the (R)-Monophos complex (R)-1. The results are re-
ported in Scheme 4. From these experiments, it appears
that: (a) a substantial but partial transfer of chirality from
enantiomerically enriched 3d (Ͼ95% ee) takes place when
using PtCl2 as the catalyst, which leads to the final product
4 in 54% enantiomeric excess (Entry 2); (b) when using the
platinacyclic catalyst 1a, the stereochemical control from
2
1.06 (s, 3 H, Me), 1.24 (m, 1 H, CH2), 2.48 (d, J = 19.0 Hz, 1 H,
2
2
4
CH2), 2.63 (d, J = 19.0 Hz, 1 H, CH2), 2.67 (dq, J = 19.0, J =
2.0 Hz, 1 H, CH2), 2.92 (dq, J = 19.0, J = 2.0 Hz, 1 H, CH2), 7.25–
7.4 (5 H, Ph) ppm. 13C NMR (75 MHz, CDCl3): δ = 18.6 (Me),
the chiral catalyst overcomes the effect of the chiral sub- 23.8 (CH2), 26.1 (C), 33.5 (C), 48.3 (CH2), 50.3 (CH2), 126.6, 128.5,
129.2, 140.1 (C), 216.4 (CO) ppm. ESI-MS: m/z = 187 [M + H]+.
Enantiomeric excesses were measured by chiral HPLC: Chiracel
AD-H, heptane/2-propanol 99:1, 1 mL/min, retention times 4.4 and
strate (Entries 2 and 3); (c) the (R)-configured substrate
(R)-3d constitutes a matching pair with the (R)-Monophos
complex (R)-1a, which allows the desired cycloisomeriza-
tion product 4 to be obtained in 92% enantiomeric excess.
The same catalyst converts the (S)-configured substrate into
4 with 35% ee (Entries 3 and 4). These results are fully
consistent with the 63% ee obtained in the cycloisomeriza-
tion of racemic 3d.
5.3 min. Racemic
isomerization.
4 was obtained by PtCl2-promoted cyclo-
Supporting Information (see footnote on the first page of this arti-
cle): Further experimental procedures and characterization details
of the compounds and an ORTEP diagram of the S-configuration
of the propargylic carbon of (SCH)-6b are presented.
Acknowledgments
We would like to thank the COST action (CM0802) “PhoSciNet”
for support.
[1] a) E. Jiménez-Núñez, A. Echavarren, Chem. Rev. 2008, 108,
3326–3350; b) V. Michelet, P. Y. Toullec, J.-P. Genet, Angew.
Chem. 2008, 120, 4338; Angew. Chem. Int. Ed. 2008, 47, 4268–
4315; c) A. Fürstner, Chem. Soc. Rev. 2009, 38, 3208; d) I. J. S.
Fairlamb, Angew. Chem. 2004, 116, 1066; Angew. Chem. Int.
Ed. 2004, 43, 1048–3221.
[2] V. Mamane, T. Gress, H. Krause, A. Fürstner, J. Am. Chem.
Soc. 2004, 126, 8654–8655.
[3] Y. Harrak, C. Blaszykowski, M. Bernard, K. Cariou, E. Mai-
netti, V. Mouriès, A.-L. Dhimane, L. Fensterbank, M. Malac-
ria, J. Am. Chem. Soc. 2004, 126, 8656–8657.
[4] a) C. Fehr, J. Galindo, Angew. Chem. 2006, 118, 2967; Angew.
Chem. Int. Ed. 2006, 45, 2901–2904; b) A. Fürstner, P. Hannen,
Chem. Eur. J. 2006, 12, 3006–3019; c) C. Fehr, B. Winter, I.
Magpantay, Chem. Eur. J. 2009, 15, 9773–9784.
Scheme 4. Catalytic cycloisomerizations of the enantiomerically en-
riched substrates 3d.
These results highlight a significant role of the stereo- [5] A. Fürstner, P. Hannen, Chem. Commun. 2004, 2546–2547.
genic center of oxygen-functionalized 1,5-enynes in the
stereochemical outcome of the targeted cycloisomeriza-
tions. They also show that the configuration of the stereo-
[6] A. Fürstner, A. Schlecker, Chem. Eur. J. 2008, 14, 9181–9191.
[7] C. Fehr, M. Vuagnoux, A. Buzas, J. Arpagaus, H. Sommer,
Chem. Eur. J. 2011, 17, 6214–6220.
[8] a) D. Brissy, M. Skander, P. Retailleau, A. Marinetti, Organo-
genic center does not simply translate into the stereochemis-
try of the product, and, therefore, chiral induction can be
carried out by means of chiral catalysts. The above results
also demonstrate that the platinacyclic Monophos com-
plexes 1 display high catalytic activity and have the poten-
metallics 2007, 26, 5782–5785; b) D. Brissy, M. Skander, P. Re-
tailleau, G. Frison, A. Marinetti, Organometallics 2009, 28,
140–151; c) D. Brissy, M. Skander, H. Jullien, P. Retailleau, A.
Marinetti, Org. Lett. 2009, 11, 2137–2139; d) H. Jullien, D.
Brissy, R. Sylvain, P. Retailleau, J.-V. Naubron, S. Gladiali, A.
Marinetti, Adv. Synth. Catal. 2011, 353, 1109–1124.
tial of inducing high stereocontrol in these cycloisomeriza- [9] a) A. Fürstner, P. W. Davies, Angew. Chem. 2007, 119, 3478;
tions.
Angew. Chem. Int. Ed. 2007, 46, 3410–3449; b) S. I. Lee, N.
Chatani, Chem. Commun. 2009, 371–384.
[10] a) E. Soriano, J. Marco-Contelles, J. Org. Chem. 2005, 70,
9345–9353; b) E. Soriano, J. Marco-Contelles, Acc. Chem. Res.
Experimental Section
2009, 42, 1026–1036.
[11] a) C. Blaszykowski, Y. Harrak, M.-H. Gonçalves, J.-M.
Typical Procedure for the Enantioselective Cycloisomerizations
Cloarec, A.-L. Dhimane, L. Fensterbank, M. Malacria, Org.
Propargylic alcohol 3a[16] was prepared by 2,3-Wittig rearrange-
Lett. 2004, 6, 3771–3774; b) F. Gagosz, Org. Lett. 2005, 7,
4129–4132; c) C. Blaszykowski, Y. Harrak, C. Brancour, K.
Nakama, A.-L. Dhimane, L. Fensterbank, M. Malacria, Syn-
thesis 2007, 2037–2049.
ment of the corresponding allyl propargyl ether.[17]
5-methyl-1-phenylbicyclo[3.1.0]hexan-3-one (4): AgBF4 (4 mg,
0.02 mmol) and enyne 3a (50 mg, 0.16 mmol, in 4.5 mL of toluene)
were added sequentially to a solution of PtII complex 1a[8d]
[12] The reactions proceed with an AgI to PtII ratio of 1:1. However,
for practical reasons, an excess of AgBF4 (3:1 ratio) was rou-
Eur. J. Inorg. Chem. 2011, 5083–5086
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
5085